Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon.
The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Global Health Limited (GHL) was incorporated as `Global Health Private Limited` on August 13, 2004 at New Delhi, India as a Private Limited Company. The Company converted into a Public Limited Company and name of the Company was changed to `Global Health Limited` dated August 11, 2021 issued by the RoC.
As of Jul 09, 2025 04:10 PM, the market cap of Global Health Ltd stood at Rs. 34,344.22 Cr. Global Health · Mkt Cap: 32,717 Crore (down -3.38% in 1 year) · Revenue: 3,692 Cr · Profit: 481 Cr · Stock is trading at 9.66 times its book value · Promoter Holding: 33.0% The company trades on both NSE and BSE with the symbol MEDANTA.
Global Health operates five hospitals under the "Medanta" brand in Gurugram, Indore, Ranchi, Lucknow, and Patna, with one more hospital under construction in Noida. The company provides services in over 30 medical specialties, employing 1,750+ doctors across a total area of 4.7 million square feet. The operational hospitals have 3,008 installed beds. In addition, Global Health runs 6 multi-specialty clinics in locations such as DLF Cybercity Gurugram, Delhi Airport, South Delhi, Darbhanga, Patna, and Subhash Chowk Gurugram.
In November 2009, the Company opened its flagship hospital in Gurugram. In 2019, it commenced operations of new hospital at Lucknow. In 2020, Patna hospital`s outpatient department facility was launched and the inpatient department facility of its Patna hospital was inaugurated in October 2021, which commenced operations during year 2022.
For the full year,net profit rose 0.68% to Rs 481.44 crore in the year ended March 2025 as against Rs 478.19 crore during the previous year ended March 2024. Sales rose 12.74% to Rs 3692.32 crore in the year ended March 2025 as against Rs 3275.11 crore during the previous year ended March 2024.
Net profit of Global Health declined 20.40% to Rs 101.40 crore in the quarter ended March 2025 as against Rs 127.38 crore during the previous quarter ended March 2024. Sales rose 15.16% to Rs 931.25 crore in the quarter ended March 2025 as against Rs 808.63 crore during the previous quarter ended March 2024.
Global Health Ltd, operating under the Medanta brand, plans to invest Rs 4,000 crore to expand its capacity to 6,000 beds, focusing on new hospitals in Noida, Guwahati, and Mumbai. The expansion aims to enhance healthcare services and includes maintenance for existing facilities.
Global Health 'Medanta' announced its entry into the North East with its plan to establish a super speciality hospital in Guwahati. The Board of Directors, in its meeting held today, approved the purchase of 3 acres of land from Assam Electricity Grid Corporation for Rs. 30 crore plus incidental expenses for registration and possession of the land.
It provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media.
The company primarily offers treatments in the areas of lung transplant, mother and child care, neonatology, URO-oncology, paediatric, pulmonology, oncology, orthopaedics, urology, endocrine surgery, gastroenterology, Psychiatry, surgical and radiation oncology, as well as ENT, blood bank, and chest related services. It also offers digestive and hepatobiliary sciences, musculoskeletal disorders and orthopedics, critical care and anesthesiology, endocrinology and diabetology, nephrology, obstetrics, dermatology, ophthalmology, dental, liver transplant, kidney, and various specializations, as well as ayurvedic medicine.
Crisil Ratings stated that GHL's Revenue reported 12% on-year growth in the first nine months of fiscal 2025, driven by increase in inpatient volumes owing to bed expansion, improvement in average revenue per occupied bed (ARPOB) and sustenance of occupancy levels on year on-year basis. Operating profitability moderated by 50 basis points (bps) to 24.1% in the first nine months of fiscal 2025 due to decline in operating profitability in the Lucknow hospital while the Patna (Bihar) and Gurugram (Haryana) hospitals registered stable profitability.
Global Health Ltd continues to strengthen its position as a leading healthcare provider in India, with robust expansion plans and a comprehensive network of medical facilities serving patients across multiple specialties.
